TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
Part of paid clinical trials in Laguna Hills, California.
- Sponsor
- Linda Chan, MD
- Study ID
- NCT04552509
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Stereotactic Body Radiotherapy — RADIATIONTreatment of prostate cancer with stereotactic body radiation therapy (SBRT)
Study Details
The purpose of this study is to determine the effects of TrueBeam stereotactic body radiosurgery in patients with prostate cancer. The device is designed to concentrate large doses of radiation onto the tumor so that injury from radiation to the nearby normal tissue will be minimal. The purpose of this evaluation is to see if this treatment will help patients with your condition and to evaluate the effect of this treatment on your quality of life over time. Radiosurgery is a non-invasive treatment technique used to treat tumors. Despite the word "surgery" in the name, the technology does not remove the tumor with a surgical knife. Instead, a focused, high-intensity beam of radiation targets the tumor, while minimizing dose to surrounding normal healthy tissue.
Key Dates
- Start date
- Jun 5, 2018
- Status verified
- May 2025
- Primary completion
- Dec 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 167 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: ObservationObservational study of patient efficacy and side effects
Primary Outcome Measure
Local control [ Time Frame: 5 years ]
Central Contacts
- Linda Chan, MD562-933-0300
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MemorialCare Saddleback Medical Center | Laguna Hills | California | 92653 |
Find similar trials in Laguna Hills, CA
Related Studies
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- SBRT Boost for Unfavorable Prostate Cancer'Recruiting · MemorialCare Health System · Fountain Valley, California
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerEARLY_PHASE1 · Recruiting · Ivan de Kouchkovsky, MD · San Francisco, California
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska